About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Venmax Drugs And Pharmaceuticals Ltd.
BSE Code
531015
ISIN Demat
INE154G01022
Book Value
-1.27
NSE Code
NA
Dividend Yield %
0.00
Market Cap
136.58
P/E
0.00
EPS
-0.02
Face Value
10
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
25-Jun-2025
26.30
26.30
26.07
26.07
755
19797
24-Jun-2025
27.47
27.47
26.60
26.60
2808
75134
23-Jun-2025
27.50
27.50
26.95
26.95
1305
35170
20-Jun-2025
28.00
28.00
27.50
27.50
276
7654
19-Jun-2025
27.50
28.00
27.50
28.00
134
3730
18-Jun-2025
27.50
27.50
27.50
27.50
205
5637
17-Jun-2025
27.54
27.54
26.99
26.99
1118
30183
16-Jun-2025
25.51
27.93
25.51
27.54
1510
39012
13-Jun-2025
26.20
28.19
25.54
26.61
32446
855062
12-Jun-2025
28.05
28.05
26.85
26.88
7933
216825
11-Jun-2025
26.70
26.72
26.70
26.72
9150
244480
10-Jun-2025
25.45
25.45
25.45
25.45
6739
171507
09-Jun-2025
23.99
24.24
23.99
24.24
6642
159468
06-Jun-2025
23.99
24.79
23.08
23.09
5858
137468
05-Jun-2025
24.18
24.99
22.98
24.00
8472
199877
04-Jun-2025
25.60
25.60
23.31
24.18
16482
384247
03-Jun-2025
24.52
26.00
24.52
24.53
10161
250037
02-Jun-2025
26.20
26.20
23.85
25.63
4251
103044
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.